Insider · CIK 0001775394

Funtleyder Leslie D.

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001775394

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-03	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−16.5K sh	—	—	0
2026-02-03	APLTApplied Therapeutics, Inc.U Disposition from Tender	Director, Chief Financial Officer	UDisposition from Tender	−153K sh	—	—	0
2026-02-03	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−20.5K sh	—	—	0
2026-02-03	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−40.5K sh	—	—	0
2026-02-03	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−150K sh	—	—	0
2026-02-03	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−16.5K sh	—	—	0
2026-02-03	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−10.2K sh	—	—	0
2026-02-03	APLTApplied Therapeutics, Inc.D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−2.38M sh	—	—	152,959
2026-01-01	APLTApplied Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+150K sh	—	—	1,340,459
2025-12-19	APLTApplied Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+1.19M sh	—	—	2,527,959
2025-12-18	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director	AAward	+8,200 sh	—	—	8,200
2025-10-01	APLTApplied Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+150K sh	—	—	1,190,459
2025-07-01	APLTApplied Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+150K sh	—	—	937,121
2025-06-09	APLTApplied Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+150K sh	—	—	787,121
2025-03-24	APLTApplied Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+350K sh	—	—	740,459
2025-03-04	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−14.5K sh	$0.44	−$6,380.88	390,459
2025-02-06	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−23K sh	$0.61	−$14K	404,961
2024-12-19	APLTApplied Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+150K sh	—	—	427,911
2024-12-19	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+150K sh	—	—	150,000
2024-12-10	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director	AAward	+8,200 sh	—	—	8,200
2024-08-22	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−13.5K sh	$5.83	−$78.9K	277,911
2024-06-06	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−17K sh	$4.32	−$73.4K	291,441
2024-03-14	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−28.7K sh	$5.39	−$155K	308,421
2023-11-20	APLTApplied Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+300K sh	—	—	337,148
2023-11-13	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director	AAward	+8,200 sh	—	—	8,200
2023-06-06	APLTApplied Therapeutics, Inc.A Award	Director, Chief Financial Officer	AAward	+20K sh	—	—	37,148
2022-11-10	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director	AAward	+3,900 sh	—	—	3,900
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	+16.5K sh	—	—	16,500
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	+20.5K sh	—	—	20,460
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−20.5K sh	—	—	0
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	+10.2K sh	—	—	10,230
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−10.2K sh	—	—	0
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−16.5K sh	—	—	0
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	+16.5K sh	—	—	16,500
2022-08-02	APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)D Disposition to Issuer	Director, Chief Financial Officer	DDisposition to Issuer	−16.5K sh	—	—	0
2022-06-03	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+16.5K sh	—	—	16,500
2021-12-08	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2021-06-15	RVPHREVIVA PHARMACEUTICALS HOLDINGS, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2021-06-03	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director, Chief Financial Officer	AAward	+16.5K sh	—	—	16,500
2020-10-02	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−5,976 sh	$20.07	−$120K	17,148
2020-10-01	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Financial Officer	MExercise/Conversion	−30K sh	—	—	40,502
2020-10-01	APLTApplied Therapeutics, Inc.M Exercise/Conversion	Director, Chief Financial Officer	MExercise/Conversion	−30K sh	$4.70	−$141K	47,148
2020-10-01	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−22.7K sh	$20.03	−$454K	24,477
2020-10-01	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−1,353 sh	$20.75	−$28.1K	23,124
2020-08-24	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	+6,461 sh	$24.18	+$156K	17,148
2020-08-24	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−13.5K sh	$23.42	−$317K	23,609
2020-08-21	APLTApplied Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Financial Officer	MExercise/Conversion	−20K sh	—	—	70,502
2020-08-21	APLTApplied Therapeutics, Inc.M Exercise/Conversion	Director, Chief Financial Officer	MExercise/Conversion	−20K sh	$4.70	−$94K	37,148
2020-06-25	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−100 sh	$38.28	−$3,828	17,148
2020-06-25	APLTApplied Therapeutics, Inc.S Sale	Director, Chief Financial Officer	SSale	−200 sh	$36.12	−$7,224	17,765

Recent filings

Accepted (ET)
Feb 34
Funtleyder Leslie D.0001193125-26-036140
SEC(opens sec.gov)
Jan 24
Funtleyder Leslie D.0001193125-26-001156
SEC(opens sec.gov)
Dec 194
Funtleyder Leslie D.0001437749-25-038446
SEC(opens sec.gov)
Oct 14
Funtleyder Leslie D.0001193125-25-227148
SEC(opens sec.gov)
Jul 34
Funtleyder Leslie D.0000950170-25-093555
SEC(opens sec.gov)
Mar 264
Funtleyder Leslie D.0000950170-25-045613
SEC(opens sec.gov)
Mar 64
Funtleyder Leslie D.0000950170-25-035041
SEC(opens sec.gov)
Feb 74
Funtleyder Leslie D.0000950170-25-016588
SEC(opens sec.gov)
Dec 204
Funtleyder Leslie D.0000950170-24-139239
SEC(opens sec.gov)
Dec 124
Funtleyder Leslie D.0001437749-24-037370
SEC(opens sec.gov)

Companies

Address

C/O APPLIED THERAPEUTICS, INC. 545 FIFTH AVENUE, SUITE 1400

NEW YORK, NY, 10017